18 September 2017 3 604 Report

I am trying to understand validation better. 

Are real patient samples required to test % recovery and specificity?.

I was told that you would need this for electrochemistry because of oxidation/ reduction but HPLC-UV should be assumed to be selective enough to differentiate the analytes.

For the previous validation using electrochem analyte calibration curve was determined with slight concentrations of the other analytes.

For HPLC-UV I did individual standard biomarker calibration curve for a separate detection method that I developed.

how does one test for sensitivity?

when for LOD the concentration is decreased to minimal 3:1 visual detection. (10 blank runs LOD calculation vs  peak area set concentration to three times peak area of blank peak, calculations gave different results hence visual detection was simpler to apply to start with lowest and go to lower analyte concentration.

https://www.fda.gov/downloads/drugs/guidances/ucm368107.pdf

for recovery this doc says to use biological matrix and add background analytes.

For sensitivity its the LLOQ of limit of quantification. Therefore how does one get LOQ and what is the lower limit is it 25% of the LOQ graph?.

More Mel Gibson's questions See All
Similar questions and discussions